Artificial Tears Market By Type (Cellulose Derived, Glycerine Derived, and Oil Based Emulsion Tears), By Delivery Method (Eye Drops and Ointments), By Application (Dry Eyes Treatment and Contact Lenses Moisture), and By Region - Market Trends, Analysis, and Forecast till 2034

Artificial Tears Market was valued at USD 3.44 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% to reach USD 6.19 billion by 2034.

Artificial tears work as lubricants eye drops that are used for treating the irritation and dryness related with the deficiency in tear production in dry eyes or kerato conjunctivitis sicca. Artificial tears are used for moistening contact lenses and at the time of eye checkups and examinations. This product is employed for the aim of treating problems caused because of dryness and irritation. These artificial tears are made by using salts, water, and polymers. However, these artificial tears don't inherit proteins which are present in real tears. It is often purchased in any pharmacy or medical unit. For instance, the world population living in the area is projected to increase from 55% in 2018 to 68% in 2050. This is further supported by rising prevalence of dry eye disease coupled with rising demand of eye drops. According to the study published in the American Journal of Opthalmology, the annual prevalence of dry eye disease increased from 0.8% to 3.0% from 2005 to 2012.

Impact of Covid-19 pandemic on market

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the product segment. Government across the countries has imposed strict lockdown to limit the spread of disease. The pandemic has profoundly changed our everyday lives. During lockdown, opportunities for venturing outside were significantly limited; in Italy, people weren’t even allowed to go outside for walks or exercise, and in other countries there were strict time limits imposed. This has been a real problem for patients with dry eye disease, as low humidity and restricted airflow indoors can induce or exacerbate the condition. This report will quantify the impact of pandemic on artificial tears market.

One of the major drivers of the artificial tears market is the growing prevalence of dry eye syndrome (DES) owing to several factors such as prolonged exposure to digital displays, rising pollution levels, protein and vitamin deficiencies, and climatic changes. The growing geriatric population and rising number of eye surgeries that demands the use of artificial tears for post-surgery management are also boosting the market growth.

Increasing use of contact lenses

Increasing use of contact lenses, digital workloads among individuals and development of innovation products are some factors expected to create potential revenue opportunities for players operating in the global market over the forecast period. In addition, development of preservative free artificial tear gas, owing to resolve its side-effects are another factor expected to create lucrative opportunity for the target market over the forecast period.

The artificial tears market is segmented based on type, delivery method, application and region.

On the basis of type, the global artificial tears market is segmented into cellulose derived, glycerine derived, and oil based emulsion tears. Based on delivery method, the target market is segmented into eye drops, and ointments. Based on application, the target market segmented into dry eyes treatment, and contact lenses moisture.

On region the global artificial tears market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to dominate in the global market in terms of revenue over the forecast period, owing to rising awareness of product and availability of advanced products across various countries in the region. The market in Europe is expected to register significant growth in terms of revenue over the forecast period, owing to presence of wide verity of products and manufacturers across various countries in the region. The market in Asia Pacific is expected to register highest market share over the forecast period, owing to rising incidences of Dry Eye Syndrome (DES) across various countries in the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the global artificial tears market report based on type, delivery mode, application and region.

Global Artificial Tears Market, By Type:

• Cellulose Derived
• Glycerine Derived
• Oil Based Emulsion Tears

Global Artificial Tears Market, By Delivery Mode:

• Eye Drops
• Ointments

Global Artificial Tears Market, By Application:

• Dry Eyes Treatment
• Contact Lenses Moisture

Global Artificial Tears Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the artificial tears market includes Abbott Medical Optics Inc., Akorn, Inc., Alcon Laboratories, Inc., Allergan Plc, Aura Labs Ltd., Bausch & Lomb Incorporation, Bayer Ag, Carl Zeiss Ag, Essilor International S.A, and Hoya Corporation. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, In February 2017, Johnson and Johnson acquired three business segment of Abbot Medical Optics, namely, consumer eye health, contract surgery, and laser refractive surgery. The acquisitions were done to expand its global footprint as well as expand the consumer base across the globe.

• Abbott Medical Optics Inc.
• Akorn, Inc.
• Alcon Laboratories, Inc.
• Allergan Plc
• Aura Labs Ltd.
• Bausch & Lomb Incorporation
• Bayer Ag
• Carl Zeiss Ag
• Essilor International S.A
• Hoya Corporation